Background First-pass effect (FPE), restoring complete or near complete reperfusion (modified Thrombolysis in Cerebral Infarction (mTICI) 2c-3) in a single pass, is an independent predictor for good ...

Background The extended time window for endovascular therapy in adult stroke represents an opportunity for stroke treatment in children for whom diagnosis may be delayed. However, selection criteria ...

Background The long-term follow-up of asymptomatic intracranial hemorrhage (aICH) in patients with acute ischemic stroke after endovascular treatment (EVT) remains controversial. O b j e c t i v e To ...

Background The purpose of this review is to summarize the data available for the role of angiography and embolization in the comprehensive multidisciplinary management of brain arteriovenous ...

Introduction/Purpose The eShunt Implant (CereVasc, Inc., Boston, MA, USA) is a novel endovascular cerebrospinal fluid (CSF) shunt developed for the treatment of communicating hydrocephalus. The ...

Introduction Chronic subdural hematoma (cSDH) is a frequently encountered neurosurgical condition with an anticipated increase in prevalence due to the aging population. Middle meningeal artery ...

Background There is uncertainty regarding the predictors of early neurological deterioration (END) after endovascular thrombectomy in patients with acute ischemic stroke (AIS). Limited studies have ...

Conclusion This glimpse into the intracranial intravascular ischemic stroke milieu identifies an early and significant association between elevated intracranial pCO2 and a protective immune response, ...

Background Patients with end-stage renal disease (ESRD) are often excluded from clinical trials of endovascular thrombectomy (EVT). This study investigated the outcome in these patients. Methods From ...

Introduction The safety and feasibility of intravenous cangrelor use for neuroendovascular procedures needs to be investigated. Aim of Study To investigate safety and feasibility of intravenous ...

Introduction Combining the high-resolution images from a traditional 3D-DSA protocol with the longer CBCT protocol may provide simultaneous visualization of both the device and the vessel content in a ...

Introduction Glenzocimab is a monoclonal antibody fragment targeting platelet glycoprotein VI, inhibiting platelet activation and aggregation. ACTIMIS study ([NCT03803007][1]) described the safety ...